William DeVaul

Form D signer

William DeVaul

Chief Legal Officer at Cambrian BioPharma

Form D signer

Capital raised by Cambrian BioPharma

$123.8M+$123.8M latest round

1 Form D filing · first filed Jun 2026 · New York, NY

CURRENT ROLE: Chief Legal Officer
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: 2 ↗

Career

1 company on file

Cambrian BioPharmaBiotech · New York, NYsince Jun 2026

Chief Legal Officer

Signatory on Cambrian BioPharma's Form D filings · $123.8M raised across 1

Company filings

via EDGAR · Form D for Cambrian BioPharma1

DateCompanyFormAmountRole on filing

Jun 30, 2026Cambrian BioPharmaForm D+$123.8MChief Legal Officer

Form DJun 30, 2026 · Cambrian BioPharma+$123.8Mas Chief Legal Officer

Overview

Last filing Jun 30, 2026

William DeVaul is on file as Chief Legal Officer at Cambrian BioPharma in New York, NY. Cambrian BioPharma has 1 Form D filing on record, $123.8M raised in total. William DeVaul appears as a signatory on the company's filings.

Teammates

Cambrian BioPharma · 1

Lorin Van NulandDirector

Products

Cambrian BioPharma · 1

ATX-304Clinical-stage therapeutic

A pan-AMPK activator in clinical development (via pipeline company Amplifier Therapeutics) targeting age-related metabolic decline, with positive Phase 1b results in obesity and prediabetes.